Trial intelligence / Profile preview

Victoza (Liraglutide) in Type 1 Diabetes

NCT00993720Phase 3Completed

Sponsor
Copenhagen University Hospital - Hvidovre
Start
Oct 2009
Primary completion
Oct 2010
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by Copenhagen University Hospital - Hvidovre. Started Oct 2009; status: completed.

02

Drugs

03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00993720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00993720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call